Indication
Immune Tolerance
3 clinical trials
4 products
Clinical trial
Extension Study to Assess the Long-Term Safety in Recipients Who Previously Received Medeor's Cellular Immunotherapy ProductsStatus: Recruiting, Estimated PCD: 2031-12-01
Product
MDRClinical trial
A Multi-center, Prospective Study Evaluating the Rate of Inhibitor Recurrence Following Successful ITI in Patients Receiving Ongoing Once Per Weekly Factor VIII Therapy Along With Emicizumab and in Patients Who Discontinue FVIII Therapy and Are on Emicizumab for ProphylaxisStatus: Active (not recruiting), Estimated PCD: 2024-09-20
Product
FVIIIProduct
EmicizumabClinical trial
Efficacy and Safety of Immunosuppressive Withdrawal After Pediatric Liver TransplantationStatus: Not yet recruiting, Estimated PCD: 2026-12-01
Product
Tacrolimus